Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason L Schwartz

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The Milbank Quarterly|June 20, 2012
The first rotavirus vaccine and the politics of acceptable riskJason L Schwartz
American Journal of Public Health|September 26, 2018
The Spanish Flu, Epidemics, and the Turn to Biomedical ResponsesJason L Schwartz
JAMA|July 13, 2016
Vaccine Pricing and US Immunization PoliciesJason L Schwartz
American Journal of Public Health|October 20, 2017
Vaccines and the Trump Administration-Reasons for Optimism Amid UncertaintyJason L Schwartz
JAMA Pediatrics|August 4, 2018
Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease OutbreaksJason L Schwartz
The American Journal of Bioethics : AJOB|August 20, 2013
Evidence and ethics in mandatory vaccination policiesJason L Schwartz
The New England Journal of Medicine|June 18, 2025
Revised Recommendations for Covid-19 Vaccines - U.S. Vaccination Policy under ThreatJason L Schwartz
BMJ (Clinical Research Ed.)|December 16, 2020
Equitable global access to coronavirus disease 2019 vaccinesJason L Schwartz
The New England Journal of Medicine|September 23, 2020
Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public TrustJason L Schwartz
American Journal of Public Health|August 21, 2010
HPV vaccination's second act: promotion, competition, and compulsionJason L Schwartz
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The Milbank Quarterly|June 20, 2012
The first rotavirus vaccine and the politics of acceptable riskJason L Schwartz
American Journal of Public Health|September 26, 2018
The Spanish Flu, Epidemics, and the Turn to Biomedical ResponsesJason L Schwartz
JAMA|July 13, 2016
Vaccine Pricing and US Immunization PoliciesJason L Schwartz
American Journal of Public Health|October 20, 2017
Vaccines and the Trump Administration-Reasons for Optimism Amid UncertaintyJason L Schwartz
JAMA Pediatrics|August 4, 2018
Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease OutbreaksJason L Schwartz
The American Journal of Bioethics : AJOB|August 20, 2013
Evidence and ethics in mandatory vaccination policiesJason L Schwartz
The New England Journal of Medicine|June 18, 2025
Revised Recommendations for Covid-19 Vaccines - U.S. Vaccination Policy under ThreatJason L Schwartz
BMJ (Clinical Research Ed.)|December 16, 2020
Equitable global access to coronavirus disease 2019 vaccinesJason L Schwartz
The New England Journal of Medicine|September 23, 2020
Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public TrustJason L Schwartz
American Journal of Public Health|August 21, 2010
HPV vaccination's second act: promotion, competition, and compulsionJason L Schwartz
Pageof 6